[Federal Register Volume 77, Number 20 (Tuesday, January 31, 2012)]
[Notices]
[Pages 4820-4821]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-2002]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
World Trade Center Health Program Scientific/Technical Advisory
Committee (WTCHP STAC or Advisory Committee), National Institute for
Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meetings of the
aforementioned committee:
Committee Public Meeting Times and Dates: (All times are Eastern
Standard Time.)
12 p.m.-5 p.m., February 15, 2012. 8:30 a.m.-2 p.m., February
16, 2012.
Public Comment Times and Dates: (All times are Eastern Standard
Time.)
3:45 p.m.-4:45 p.m., on February 15, 2012. 8:45 a.m.-9:45 a.m.,
on February 16, 2012.
Place: Jacob J. Javits Federal Building, 26 Federal Plaza, New
York, New York 10278. This meeting is also available by
teleconference. Please dial 1-800-593-0693 and enter code 37121.
Status: Open to the public, limited by the capacity of the room,
which is about 70 persons, and the number of telephone lines. The
conference line will accommodate up to 300 callers; therefore it is
suggested that those interested in calling in to listen to the
committee meeting share a line when possible.
Please note that the public comment periods end at the times
indicated above or following the last call for comments, whichever
is earlier. Members of the public who want to comment must sign up.
A limited number of time slots are available and will be assigned on
a first come-first served basis. Each commenter will be provided up
to five minutes for comment. You can sign up before the meeting by
mail, facsimile, email, or telephone until all slots are filled.
When you sign up you must indicate if you will be making your
comments by telephone or in person. Advance sign up will conclude at
5 p.m. on February 13, 2012. If time slots are still available, you
will be able to sign up at the meeting beginning at 11 a.m. on
February 15 for the public comment period that day, or beginning at
8 a.m. on February 16, for the public comment period that day. To
sign up in advance of the meeting, use the contact information that
follows.
Mail: NIOSH Docket Office, Robert A. Taft Laboratories, MS-C-34,
4676 Columbia Parkway, Cincinnati, Ohio 45226.
Facsimile: (513) 533-8285.
Email: [email protected].
Telephone: (513) 533-8611.
Written comments will also be accepted (see below).
Security Considerations: Due to mandatory security clearance
procedures at the Jacob K. Javits Federal Building, in-person
attendees must present valid government-issued picture
identification to security personnel upon entering the building and
go through an airport-type security check. Non-U.S. citizens are
encouraged to participate in the audio conferencing due to the extra
clearance involved with in-person attendance. To attend in person, a
non-U.S. citizen will have to call or send an email to the contact
person in this Notice before February 1, 2012, and provide passport
information. You will be notified if clearance to attend the meeting
in person is received; otherwise, you will not be able to attend the
meeting in person.
Background: The Advisory Committee was established by Public Law
111-347 (The James Zadroga 9/11 Health and Compensation Act of 2010,
Title XXXIII of the Public Health Service Act), enacted on January
2, 2011 and codified at 42 U.S.C. 300mm-300mm-61.
Purpose: The purpose of the Advisory Committee is to review
scientific and medical evidence and to make recommendations to the
World Trade Center (WTC) Program Administrator regarding additional
WTC Health Program eligibility criteria and potential additions to
the list of covered WTC-related health conditions. Title XXXIII of
the Public Health Service Act established within the Department of
Health and Human Services (HHS), the World Trade Center (WTC) Health
Program, to be administered by the WTC Program Administrator. The
WTC Health Program provides: (1) Medical monitoring and treatment
benefits to eligible emergency responders and recovery and cleanup
workers (including those who are Federal employees) who responded to
the September 11, 2001, terrorist attacks, and (2) initial health
evaluation, monitoring, and treatment benefits to residents and
other building occupants and area workers in New York City, who were
directly impacted and adversely affected by such attacks
(``survivors''). Certain specific activities of the WTC Program
Administrator are reserved to the Secretary, HHS, to delegate at her
discretion; other WTC Program Administrator duties not explicitly
reserved to the Secretary, HHS, are assigned to the Director, NIOSH.
The administration of the Advisory Committee established under
Section 300mm-1(a) is left to the Director of NIOSH in his role as
WTC Program Administrator. CDC and NIOSH provide funding, staffing,
and administrative support services for the Advisory Committee. The
charter was issued on May 12, 2011, and will expire on May 12, 2013.
Matters To Be Discussed: The agenda for the Advisory Committee
meeting includes: discussion of the petition to add cancer to the
list of covered WTC-related health
[[Page 4821]]
conditions, research needs of the WTC Health Program, and WTC Health
Program enrollment eligibility criteria for individuals who were
members of a fire or police department (whether fire or emergency
personnel, active or retired), worked for a recovery or cleanup
contractor, or were a volunteer; and performed rescue, recovery,
demolition, debris cleanup, or other related services at the
Pentagon site or the Shanksville, Pennsylvania, site of the
terrorist-related aircraft crashes of September 11, 2001. The agenda
is subject to change as priorities dictate.
Submissions to the Docket: Written comments may be submitted.
The comments should be limited to two pages and submitted to the
contact person below by February 9, 2012. Efforts will be made to
provide the two-page written comments received by the deadline below
to the committee members before the meeting. Comments in excess of
two pages will be made publicly available at the NIOSH docket
(http://www.cdc.gov/niosh/docket/archive/docket248.html).
To provide written comments or to submit comments to the docket,
send information to the NIOSH Docket Office by one of the following
means:
Mail: NIOSH Docket Office, Robert A. Taft Laboratories, MS-C-34,
4676 Columbia Parkway, Cincinnati, Ohio 45226.
Facsimile: (513) 533-8285.
Email: [email protected].
Telephone: (513) 533-8611.
Submissions to the docket should reference docket 248.
Policy on Redaction of Committee Meeting Transcripts (Public
Comment): Transcripts will be prepared and posted to NIOSH Docket
248 within 60 days after the meeting. If a person making a comment
gives his or her name, no attempt will be made to redact that name.
NIOSH will take reasonable steps to ensure that individuals making
public comments are aware of the fact that their comments (including
their name, if provided) will appear in a transcript of the meeting
posted on a public Web site. Such reasonable steps include: (a) A
statement read at the start of the meeting stating that transcripts
will be posted and names of speakers will not be redacted; and (b) A
printed copy of the statement mentioned in (a) above will be
displayed on the table where individuals sign up to make public
comments. If individuals in making a statement reveal personal
information (e.g., medical information) about themselves, that
information will not usually be redacted. The CDC Freedom of
Information Act coordinator will, however, review such revelations
in accordance with the Freedom of Information Act and if deemed
appropriate, will redact such information. Disclosures of
information concerning third party medical information will be
redacted.
Contact Person for More Information: Paul J. Middendorf, Ph.D.,
Designated Federal Official, NIOSH, CDC, 4676 Columbia Parkway,
MailStop R-45, Cincinnati, Ohio 45226, Telephone: 1-(888) 982-4748;
email: [email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: January 25, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-2002 Filed 1-30-12; 8:45 am]
BILLING CODE 4163-18-P